RespireRx Pharmaceuticals Inc (fka RSPI)

[laker9029]

<<Messinger does not execute the CFO duties that most of her peers do--she plays no part in fundraising >>

If the latest financing, (which although necessary, was substandard in terms of quality) was done without a fully functioning, highly capable CFO, then Stoll has failed badly. This company only has 25 employees, and is financially simple --we don't need much accounting, et al. Fundraising should be one of the most strategically important roles in Cortex at this stage!

If we have traded $30 million in market cap and crippled the PPS in exchange for $14.2 million because we have a CFO who "does not execute the CFO duties" .. usually handled by CFOs in peer companies ....then that is a serious issue.

If she truly "plays no part in fundraising", I wonder, as well, what she does. Accounting for what is basically a PROJECT consisting of 25 people, expense budgets, virtualy no revenue and negative cash flow esentially equal to spending is not even a full time job.

Sorry for the whining, but for the second time in a week, I am caught badly off guard, if this is true.

I have e-mailed IR asking for an explanation of management roles and specifically Ms Messinger's role in the latest financing.

L